Concepedia

Quentin Lecocq

QL

Statistics

Publications

17

Citations

705

H-Index

16

Active since

2017

Affiliations

Vrije Universiteit Brussel(Current)

Universitair Ziekenhuis Brussel

VIB-UGent Center for Inflammation Research

University of Antwerp

Antwerp University Hospital

Quentin Lecocq is an author at Vrije Universiteit Brussel specializing in biomedical engineering, immunoengineering, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2017–2023

17

Publications

17

Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers

Katrijn Broos, Marleen Keyaerts, Quentin Lecocq et al. · Oncotarget · 2017 · 117 citations · Full text

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

Katrijn Broos, Quentin Lecocq, Catarina Xavier et al. · Cancers · 2019 · 67 citations · Full text

Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation

Jessica Bridoux, Katrijn Broos, Quentin Lecocq et al. · Biomolecules · 2020 · 67 citations · Full text

Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

Janik Puttemans, Yana Dekempeneer, Jos Eersels et al. · Cancers · 2020 · 64 citations · Full text

Therapeutic Efficacy of <sup>213</sup>Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer

Yana Dekempeneer, Vicky Caveliers, Maarten Ooms et al. · Molecular Pharmaceutics · 2020 · 54 citations

1–5 of 17